SCHEMBL7684

SCHEMBL7684

O=C(O)C(O)(C(=O)c1ccccc1)C(O)(C(=O)O)C(=O)c1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES1 P23141 7/20 0.58
SRC P12931 1/20 0.52
CES2 O00748 4/20 0.50
TSHR P16473 2/20 0.50
ALDH1A1 P00352 2/20 0.50
DAO P14920 1/20 0.50
NAPRT Q6XQN6 1/20 0.50
TDP1 Q9NUW8 4/20 0.46
MAPT P10636 3/20 0.46
CYP3A4 P08684 2/20 0.46
CA2 P00918 2/20 0.46
CA4 P22748 2/20 0.46
HSD17B10 Q99714 2/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
CA12 O43570 2/20 0.46
CA1 P00915 2/20 0.46
CA9 Q16790 2/20 0.46
POLB P06746 1/20 0.46
PARP1 P09874 1/20 0.46
CYP2C19 P33261 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL414466 1.00 CES1 (0.58) CES1SRCCES2TSHRALDH1A1
SCHEMBL31097912 1.00 CES1 (0.58) CES1SRCCES2TSHRALDH1A1
SCHEMBL2904552 1.00 CES1 (0.58) CES1SRCCES2TSHRALDH1A1
SCHEMBL32681153 1.00 CES1 (0.58) CES1SRCCES2TSHRALDH1A1
SCHEMBL637241 1.00 CES1 (0.58) CES1SRCCES2TSHRALDH1A1
SCHEMBL11542843 0.97 CES1 (0.56) CES1SRCCES2TSHRALDH1A1
Water SCHEMBL18124365 0.97 CES1 (0.56) CES1SRCCES2TSHRALDH1A1
Water SCHEMBL19283519 0.97 CES1 (0.56) CES1SRCCES2TSHRALDH1A1
Ammonia Solution, Strong SCHEMBL11444696 0.97 CES1 (0.56) CES1SRCCES2TSHRALDH1A1
Ammonia Solution, Strong SCHEMBL11444694 0.97 CES1 (0.56) CES1SRCCES2TSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 18727 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026103747-A1 SALT OF THIAZOLE DERIVATIVE INHIBITOR, CRYSTAL FORM THEREOF, PREPARATION METHOD THEREFOR AND USE THEREOF 江苏豪森药业集团有限公司 2026-05-21 WO claimed
CN-122036704-A Free base crystal form or acid salt of biaryl compound, preparation method and medical application thereof 江苏豪森药业集团有限公司 2026-05-15 CN claimed
US-20260132108-A1 PREPARATION OF MESEMBRINE KANNA HEALTH LTD (GB) 2026-05-14 US claimed
US-12624050-B2 Three fused ring derivative-containing salt or crystal form and pharmaceutical composition thereof SHANGHAI HANSOH BIOMEDICAL CO., LTD. (CN) 2026-05-12 US claimed
US-20260125390-A1 SOLID FORMS OF MACROCYCLIC COMPOUNDS, SALTS AND FORMULATIONS THEREOF, AND METHODS OF PREPARING AND USING THE SAME KURA ONCOLOGY INC (US) 2026-05-07 US claimed
EP-2556187-B1 ORGANIC-INORGANIC HYBRID NANOFIBRES HAVING A MESOPOROUS INORGANIC PHASE, PREPARATION THEREOF BY ELECTRICALLY ASSISTED EXTRUSION, MEMBRANE, ELECTRODE AND FUEL CELL COMMISSARIAT ENERGIE ATOMIQUE (FR) 2026-05-06 EP claimed
WO-2026086809-A1 PROCESS FOR PREPARING 3- [ (3AS, 6AR) -5- {5-CHLORO-2- [ (1-METHYL-1H-PYRAZOL-4-YL) AMINO] PYRIMIDIN-4-YL} -3A-METHYL-OCTAHYDROPYRROLO [3, 4-C] PYRROLE-2-YL] -3-OXOPROPIONITRILE BEIJING INNOCARE PHARMA TECH CO., LTD. (CN) 2026-04-30 WO claimed
EP-4720073-A1 SOLID FORMS OF A MACROCYCLIC FARNESYLTRANSFERASE INHIBITOR AND FORMULATIONS THEREOF, AND METHODS OF PREPARING AND USING THE MACROCYCLIC COMPOUND AND ITS SOLID FORMS Kura Oncology, Inc. (US) 2026-04-08 EP claimed
EP-4721739-A1 CSF-1R INHIBITOR PHARMACEUTICAL COMPOSITION, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF Abbisko Therapeutics Co., Ltd. (CN) 2026-04-08 EP claimed
EP-4265604-B1 OXASPIRO SUBSTITUTED PYRROLOPYRAZOLE DERIVATIVE, INTERMEDIATE THEREOF, AND PREPARATION METHOD THEREFOR SHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD (CN) 2026-04-01 EP claimed
EP-0015514-B1 OPTICALLY ACTIVE TERTIARY PHOSPHINES, PROCESS FOR THEIR PREPARATION AND USE FOR ASYMMETRICAL SYNTHESES BASF Aktiengesellschaft (DE) 1985-06-26 EP claimed
EP-0141408-A2 Process for the preparation of L(-)carnitine hydrochloride and of L(-)carnitine inner salt ISOM S.p.A. (IT) 1985-05-15 EP claimed
EP-0107825-A1 1,3,4,6,7,11b-Hexahydro-7-aryl-2H-pyrazino (2,1-alpha) isoquinolines useful as intermediates and pharmaceutical compounds and methods of preparation PENNWALT CORPORATION (US) 1984-05-09 EP claimed
EP-0092787-A1 Process for the preparation of a phenylalkylaminoethylsalicylamide SCHERING CORPORATION (US) 1983-11-02 EP claimed
US-4370500-A Compound: d-N-(2-amino-2-phenethyl)-2-methoxyethylamine and process for preparing the same by selective crystallization AMERICAN CYANAMID COMPANY (US) 1983-01-25 US claimed
US-4306082-A Optically active tertiary phosphine oxides and tertiary phosphines and processes for their preparation BASF AKTIENGESELLSCHAFT (DE) 1981-12-15 US claimed
US-4294838-A ANTIBRONCHOSPASMOLYTIC AGENTS WARNER-LAMBERT COMPANY, A CORP. OF DE 1981-10-13 US claimed
EP-0010851-A2 Process for the preparation of tetramisole AMERICAN CYANAMID COMPANY (US) 1980-05-14 EP claimed
US-4183865-A SALT FORMATION WITH (-)DIBENZOYL TARTARIC ACID IN A POLAR SOLVENT KRKA, FARMACEVTIKA, KEMIJA, KOZMETIKA, ZDRAVILISCA IN GOSTINSTVO, NOVO MESTO, N.SOL.O. (YU) 1980-01-15 US claimed
US-4072698-A OPTICALLY ACTIVE ACIDS WITH KETONE OR ALDEHYDE CATALYST THE UPJOHN COMPANY (US) 1978-02-07 US claimed